Slaven Erceg

Andalusian Molecular Biology and Regenerative Medicine Centre, Spain

Dr. Erceg has more than six years of postdoctoral experience dedicated to cell therapy involving human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs), as a therapeutic tool for treatment of neurodegenerative diseases. He developed an improved protocol for differentiation of hESCs and iPSCs toward neural progenitors, oligodendrocytes and motoneurons, for the treatment of rat model of spinal cord injury (Erceg et al., 2008, Erceg et al., 2010a), and cerebellar neuronal progenitors for the treatment of animal cerebellar ataxia models (Erceg et al., 2010b, Erceg et al., 2011). Recently he has extended his interest to rare retinal diseases and is currently developing a study on the therapeutic potential of pluripotent cells in retinal degenerative disease involving gene correction In total he produced 40 papers as main and co-author in high ranking journals like Stem Cells, Stem Cells and Development, Neuroscience, Hepathology etc Currently he is holding the position of independent investigator contracted by Spanish Ministry of Health in Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), Seville, Spain, and 2 research grants.

Biography Updated on 23 June 2013

Scholarly Contributions [Data Provided by scopus]